Neo New Oncology Gmbh competitive analysis

Explore patent oppositions filed by Neo New Oncology Gmbh against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition Date
Methods And Materials For Assessing Homologous Recombination DeficiencyMYRIAD GENETICSDec 10, 2020
Methods And Materials For Assessing Homologous Recombination DeficiencyABKEVICHSep 15, 2020
Methods And Materials For Assessing Allelic ImbalanceGUTINSep 10, 2020
Methods And Materials For Assessing Loss Of HeterozygosityABKEVICHAug 13, 2020

Latest PTAB cases involving Neo New Oncology Gmbh

Discover the latest PTAB cases involving Neo New Oncology Gmbh, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Neo New Oncology Gmbh with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NEO NEW ONCOLOGY GMBH4 - - -
GUTIN - 7 - -
MYRIAD GENETICS - 1249
TIMMS - 7 - -